Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Derlin

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2020
Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapyChristoph Henkenberens, Ann-Kathrin Oehus, Thorsten Derlin, et al.
Abdominal Radiology (New York)|November 26, 2016
CT angiography in the setting of suspected acute mesenteric ischemia: prevalence of ischemic and alternative diagnosesFrank Oliver Henes, Perry J Pickhardt, Andrzej Herzyk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Initial Experience with Volumetric <sup>68</sup>Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate CancerSebastian Schmuck, Christoph A von Klot, Christoph Henkenberens, et al.
Clinical Nuclear Medicine|April 25, 2018
Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary HypertensionThorsten Derlin, Catharina Kelting, Katja Hueper, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 9, 2016
(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapyChristoph Henkenberens, Christoph A von Klot, Tobias L Ross, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 23, 2012
Diffusion-weighted imaging of the healthy pancreas: ADC values are age and gender dependentJochen Herrmann, Bjoern P Schoennagel, Magdalena Roesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2022
Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional OutcomeJohanna Diekmann, Tobias Koenig, James T Thackeray, et al.
Nuklearmedizin. Nuclear Medicine|January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate CancerSteven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2023
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factorsAleksander Kosmala, Sebastian E Serfling, Kerstin Michalski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Comparison of standard and delayed imaging to improve the detection rate of [<sup>68</sup>Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancerSebastian Schmuck, Stefan Nordlohne, Christoph-A von Klot, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2020
Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapyChristoph Henkenberens, Ann-Kathrin Oehus, Thorsten Derlin, et al.
Abdominal Radiology (New York)|November 26, 2016
CT angiography in the setting of suspected acute mesenteric ischemia: prevalence of ischemic and alternative diagnosesFrank Oliver Henes, Perry J Pickhardt, Andrzej Herzyk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Initial Experience with Volumetric <sup>68</sup>Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate CancerSebastian Schmuck, Christoph A von Klot, Christoph Henkenberens, et al.
Clinical Nuclear Medicine|April 25, 2018
Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary HypertensionThorsten Derlin, Catharina Kelting, Katja Hueper, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 9, 2016
(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapyChristoph Henkenberens, Christoph A von Klot, Tobias L Ross, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 23, 2012
Diffusion-weighted imaging of the healthy pancreas: ADC values are age and gender dependentJochen Herrmann, Bjoern P Schoennagel, Magdalena Roesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2022
Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional OutcomeJohanna Diekmann, Tobias Koenig, James T Thackeray, et al.
Nuklearmedizin. Nuclear Medicine|January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate CancerSteven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2023
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factorsAleksander Kosmala, Sebastian E Serfling, Kerstin Michalski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Comparison of standard and delayed imaging to improve the detection rate of [<sup>68</sup>Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancerSebastian Schmuck, Stefan Nordlohne, Christoph-A von Klot, et al.
Pageof 20